Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Disubstituted Urea. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel copper-catalyzed route for disubstituted urea intermediates. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical partners.
Patent CN119462433A details high-selectivity urea synthesis. Offers supply chain stability and cost efficiency for agrochemical intermediate manufacturing partners globally.
Patent CN102408392A details a green aqueous synthesis for 2-(N,N-disubstituted amino)-4-thiazolinone. This method offers high yields, reduced costs, and scalable production for pharma intermediates.
Novel Ru-catalyzed method for symmetric ureas offers mild conditions and high selectivity, reducing manufacturing costs for pharmaceutical intermediates.
Patent CN1298402A reveals a safer synthesis route for anti-arrhythmic agents, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.